Casey Mulligan, PhD, has been appointed chief economist and chief regulatory officer at HHS, according to his LinkedIn page.
Axios reported the news April 16, noting Dr. Mulligan will advise HHS Secretary Robert F. Kennedy Jr. and other agency leaders on affordability issues.
His appointment comes as the availability and affordability of healthcare top the list of Americans’ concerns about key issues, according to a March 31 Gallup article. The findings are based on telephone interviews conducted with 1,000 U.S. adults.
Dr. Mulligan most recently served as chief counsel for advocacy at the U.S. Small Business Administration. He also served as chief economist on the Council of Economic Advisers during the first Trump administration.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
